Phenotypic and Genotypic Profiling of MDM2, Respective to the TP53 Genetic Status, in Diffuse Large B-cell Lymphoma Patients Treated With Rituximab-CHOP Immunochemotherapy: A Report from the International DLBCL Rituximab-CHOP Consortium Program
Published
Conference Paper
Full Text
Duke Authors
Cited Authors
- Xu-Monette, ZY; Møller, MB; Tzankov, A; Montes-Moreno, S; Hu, W; Manyam, GC; Kristensen, L; Fan, L; Visco, C; Dybkær, K; Chiu, A; Tam, W; Zu, Y; Bhagat, G; Richards, KL; Hsi, ED; Choi, WWL; van Krieken, JH; Huang, Q; Huh, J; Ai, W; Ponzoni, M; Ferreri, AJM; Wu, L; Zhao, X; Bueso-Ramos, CE; Wang, SA; Go, RS; Li, Y; Winter, JN; Piris, MA; Medeiros, LJ; Young, KH
Published Date
- September 2014
Published In
Volume / Issue
- 14 /
Start / End Page
- S146 - S147
Published By
International Standard Serial Number (ISSN)
- 2152-2650
Digital Object Identifier (DOI)
- 10.1016/j.clml.2014.06.085